These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Neuropathological correlates of memory dysfunction in the Wernicke-Korsakoff syndrome. Halliday G; Cullen K; Harding A Alcohol Alcohol Suppl; 1994; 2():245-51. PubMed ID: 8974343 [TBL] [Abstract][Full Text] [Related]
28. Propranolol in the treatment of rage and violent behavior associated with Korsakoff's psychosis. Yudofsky SC; Stevens L; Silver J; Barsa J; Williams D Am J Psychiatry; 1984 Jan; 141(1):114-5. PubMed ID: 6691426 [TBL] [Abstract][Full Text] [Related]
29. Memory impairment in Korsakoff's psychosis: a correlation with brain noradrenergic activity. McEntee WJ; Mair RG Science; 1978 Nov; 202(4370):905-7. PubMed ID: 715450 [TBL] [Abstract][Full Text] [Related]
30. Effects of oral physostigmine and lecithin on memory and attention in closed head-injured patients. Levin HS; Peters BH; Kalisky Z; High WM; von Laufen A; Eisenberg HM; Morrison DP; Gary HE Cent Nerv Syst Trauma; 1986; 3(4):333-42. PubMed ID: 3555852 [TBL] [Abstract][Full Text] [Related]
31. Further evidence for a comparable memory advantage of self-performed tasks in Korsakoff's syndrome and nonamnesic control subjects. Mimura M; Komatsu S; Kato M; Yoshimasu H; Moriyama Y; Kashima H J Int Neuropsychol Soc; 2005 Sep; 11(5):545-53. PubMed ID: 16212681 [TBL] [Abstract][Full Text] [Related]
32. Korsakoff's syndrome: a study of the relation between anterograde amnesia and remote memory impairment. Shimamura AP; Squire LR Behav Neurosci; 1986 Apr; 100(2):165-70. PubMed ID: 3964418 [TBL] [Abstract][Full Text] [Related]
33. Improved verbal learning after outpatient oral physostigmine therapy in patients with dementia of the Alzheimer type. Sevush S; Guterman A; Villalon AV J Clin Psychiatry; 1991 Jul; 52(7):300-3. PubMed ID: 2071560 [TBL] [Abstract][Full Text] [Related]
34. Choline chloride effects on memory: correlation with the effects of physostigmine. Mohs RC; Davis KL Psychiatry Res; 1980 May; 2(2):149-56. PubMed ID: 6932060 [TBL] [Abstract][Full Text] [Related]
35. Some comparisons of the memory and visuoperceptive deficits of chronic alcoholics and patients with Korsakoff's disease. Butters N; Cermak LS; Montgomery K; Adinolfi A Alcohol Clin Exp Res; 1977 Jan; 1(1):73-80. PubMed ID: 337826 [No Abstract] [Full Text] [Related]
36. Memory improvement in Korsakoff's disease with fluvoxamine. McEntee WJ; Mair RG Arch Gen Psychiatry; 1990 Oct; 47(10):978-9. PubMed ID: 2121117 [No Abstract] [Full Text] [Related]
37. The nature of the memory deficit in Korsakoff's psychosis. Murray DJ; Hitchcock CH Can J Psychol; 1973 Dec; 27(4):414-21. PubMed ID: 4766147 [No Abstract] [Full Text] [Related]
38. Fluvoxamine treatment of alcoholic amnestic disorder. Martin PR; Adinoff B; Lane E; Stapleton JM; Bone GA; Weingartner H; Linnoila M; Eckardt MJ Eur Neuropsychopharmacol; 1995 Mar; 5(1):27-33. PubMed ID: 7542052 [TBL] [Abstract][Full Text] [Related]
39. Physostigmine effects in Alzheimer's disease: relationship to dementia severity. Schwartz AS; Kohlstaedt EV Life Sci; 1986 Mar; 38(11):1021-8. PubMed ID: 3512944 [TBL] [Abstract][Full Text] [Related]